Paper
Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
Published Jun 1, 2008 · J. Zohar, R. Amiaz, A. Gershon
European Neuropsychopharmacology
49
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
RCTStudy Snapshot
Naltrexone augmentation may improve anxiety and depression symptoms in OCD patients not responding to serotonin reuptake inhibitors, but not obsessive-compulsive symptoms.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
···
···
···
···
Citations
···
···
···
···